Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06687525 · ClinicalTrials.gov registry record
Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study
A clinical trial of Alcohol Use Disorder and Alcohol Drinking, sponsored by University of Illinois at Urbana-Champaign.
- Recruiting
- Registry status
- 240
- Enrollment target
- 1
- Study location
NCT06687525: Recruiting study of Alcohol Use Disorder and Alcohol Drinking, sponsored by University of Illinois at Urbana-Champaign.
NCT06687525 is a study of Alcohol Use Disorder and Alcohol Drinking that is actively recruiting participants, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 240 participants, below the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06687525, a study of Alcohol Use Disorder and Alcohol Drinking, is actively recruiting participants, sponsored by University of Illinois at Urbana-Champaign.
- RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators aim to capture inter- and intra-brain mechanisms underlying alcohol reward in novel social context.
Primary Outcome
The association between dyad-members EEG signals during the hyperscanning task
Conditions Studied
Study Locations (1)
Illinois
- University of Illinois at Urbana-Champaign - Champaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2028-06-01 |
What NCT06687525 shows while recruiting
NCT06687525 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (27% lower).
The record links to 6 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT06687525 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06687525 about?
NCT06687525 is a clinical study titled "Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study". In this study, the investigators aim to capture inter- and intra-brain mechanisms underlying alcohol reward in novel social context.
What is the current status of trial NCT06687525?
This trial is currently recruiting. The enrollment target is 240 participants. The study started on 2024-04-05. Estimated completion is 2028-06-01.
What conditions does trial NCT06687525 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Drinking, Alcoholism, Alcohol Intoxication, Alcohol; Harmful Use.
Who is sponsoring clinical trial NCT06687525?
This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06687525 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06687525's enrollment target sits among peer trials
240 37th of 184 higher than 147 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
RECRUITING · Phase 2
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI